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IntroduCtIon
Cerebral Venous Thrombosis (CVT) re-
presents 0.5% of all strokes with an esti-
mated prevalence of 5 people in 1 million 
each year. CVT may include thrombosis of 
cerebral veins and major dural sinuses [1-4]. 
This entity has a higher prevalence in young 
women during pregnancy, puerperium or 
taking oral contraceptives [1-4]. Thrombo-
philia, infections of maxillofacial region and 
malignances are other important predispo-
sing factors [1]. Usually, CVT has a favorable 
prognosis, but it can be life-threatening in 
few cases [4]. The pathophysiological sub-
strates for central nervous system dysfun-
ction are cerebral edema, venous infarc-
tions and intracranial hypertension [1-5]. 
Magnetic Resonance Imaging (MRI) is the 
keystone for the diagnosis and follow-up [1-
Why do we describe this case?
CVT is a rare but potentially life-
threatening type of stroke that occurs 
principally in young women. From a 
pathophysiological point of view, the 
thrombosis of the cerebral venous sy-
stem increase microvascular pressure 
and blood brain barrier permeability, 
and compromise cerebrospinal fluid ab-
sorption. Cerebral edema, parenchymal 
hemorrhages, acute hydrocephalus and 
intracranial hypertension are substra-
tes for clinical presentation. Different 
syndromes are classically described; in-
tracranial hypertension (headache), focal 
deficits (paresis, aphasia), seizures and 
encephalopathy.
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Case report
Abstract
Cerebral venous sinus thrombosis (CVT) can compromise dural sinus, cerebral veins or both. 
It is an uncommon condition and it is more prevalent in young women. Several prothrombotic 
states are the principal predisposing factors. Clinical spectrum of presentation is wide, so this 
entity requires a high suspect index for correct and prompt diagnosis. CVT may develop serious 
complications that can be life-threatening such as hemorrhagic venous infarctions, cerebral 
edema, and intracranial hypertension. 
This report describes the case of a woman who was in treatment for unspecific vaginal bleeding 
with oral contraceptives. Suddenly she deteriorated to coma with severe respiratory compromise. 
Neuroimaging showed  thrombosis of multiple venous sinus. Physiological neuroprotection, 
osmotherapy, mechanical ventilation and anticoagulation therapy were the keystones of treatment. 
In a few months, the patient has recovered a good functional status, while maintaining a motor 
deficit on the right hand. 
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4]. Anticoagulation therapy, neurophysio-
logical protection [6]  and osmotherapy are 
the mainstays for acute management [1-6].
CAse report
A 54-year-old woman is admitted to the 
emergency department in a coma, with a de-
cerebration rigidity, no pupillary alterations, 
and an irregular breathing pattern. Her score 
on the Glasgow Coma Scale was 4. Vital pa-
rameters were: mean arterial pressure (MAP) 
88 mmHg, heart rate 126 beats/min (sinusal 
rhythm), central temperature 36.3 ° C (eso-
phagus), and respiratory rate 11 breaths/min. 
Three days before the patient had suffered 
from a headache and progressive left hemi-
paresis. On admission, the patient  was taking 
enalapril arterial hypertension, and oral and 
intravenous contraceptives,  started 3 months 
earlier due to non-specific vaginal bleeding. 
After an adequate and complete resuscita-
tion, including control of upper airways with 
orotracheal intubation, oxygenation, and he-
modynamic stability, she was transferred to 
the radiology department.
An unenhanced computed tomography 
(CT) scan in sagittal view showed sponta-
neously hyperintense superior longitudinal 
sinus, and bilateral occipital hemorrhagic 
infarctions.  MRI showed hemorrhagic in-
farctions and occlusion of several sinuses. 
(Figure 1). Electroencephalogram showed 
non-convulsive status epilepticus.  
After the diagnostic imaging, the patient 
was transferred to the neurointensive care 
unit. She was sedated (midazolam 3-5 mg/
kg/h), anesthetized (remifentanil 0.25-0.4 
mcg/kg/min) and mechanically ventila-
ted. Then she was treated with physiologic 
neuroprotection [5]5 and osmotherapy. At 
the same time an anticoagulation therapy 
with low weight molecular heparin (eno-
Figure 1. Neuroimaging 
at admission. 
(A) CT scan shows 
bilateral occipito-
parietal infarctions 
with hemorrhagic 
transformation and 
peri-lesional edema; 
(B) MRI in Axial 
T2-weighted image 
shows increased 
signal intensity in 
both occipital and 
left frontal lobes; 
(C) MRI venography 
demonstrating occlusion 
of superior and inferior 
sagittal (arrows) and 
(D) left transverse sinus 
(arrow)
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xaparin 1 mg/kg twice daily) and warfarin 
(5 mg/day) was started in order to obtain 
a targeted international normalized ratio 
(INR) of 2.5-3.
An exhaustive search of predisposing 
factors ruled out cancer and infections of 
the ear, paranasal sinuses, mouth or face. 
Prothrombotic predisposing causes of CVT 
(antiphospholipid syndrome, deficit an-
tithrombin III, protein C and S) were exclu-
ded. Fibrinogen and VIII factor levels were 
in the normal range, and no mutation of 
Leiden factor was found. The non-convulsive 
status epilepticus was controlled with mida-
zolam (5 mg/h) and levetiracetam (3 g/day). 
After two weeks of mechanical ventilation, 
a tracheostomy was performed. Atelectasis 
and ventilator-associated pneumonia were 
corrected with physiotherapy and antibiotics 
(imipenem 2 g/day and amikacin 1 g/day). 
A control MRI showed the recanalization 
of affected sinuses (Figure 2).
After 31 days, the patient was discharged 
to rehabilitation unit. She appeared lucid, 
oriented and in a good consciousness state 
but she has a severe paresis of her left arm 
and leg. After two months of rehabilita-
tion, neurocognitive functions have shown a 
strong recovery, even though her right hand 
still showed difficulty moving.
Figure 2. Follow 
up MRI and MRI 
venography that showed 
evolution of venous 
infarctions (A, B) 
and recanalization of 
superior and inferior 
sagittal sinuses (C )
dIsCussIon
CVT is an entity with pathophysiological, 
diagnostic and therapeutic features that dif-
fer from stroke of arterial origin [1-4]. The 
clinical spectrum of presentation is highly 
variable and can be confused with other 
entities [1-4]. The onset of symptoms may 
be acute, subacute or chronic, while signs 
and symptoms depend primarily on the lo-
cation and extent of thrombosis, as well as 
the pathophysiology of venous occlusion is 
characterized by the development of cere-
bral edema, venous infarcts and intracranial 
hypertension due to mass effect or hydro-
cephalus [1-4]. Unspecific headaches, wi-
thout characteristic features that clearly di-
stinguish them from others, are present in 
over 90% of cases.  It is therefore extremely 
important to take in mind this entity, in or-
der to avoid delays in diagnosis, especially 
in young women under contraceptives oral 
or hormonal therapy or during pregnancy 
and postpartum [1-4].
In 40% of cases, the presenting symptom 
is a focal deficit, motor (hemiparesis-plegia), 
sensory or language disorders, while in more 
than one 1/3 of cases the onset of thrombosis 
is indicated by the presence of seizures [1-4]. 
Mental status changes dominate the clinical 
What should the clinician ask him/herself or the patient?
While CVT has different presentation forms, in over 90% of cases the predominant sym-
ptom is a headache. Headaches are a very common cause of consultation, especially in young 
women. CVT is a diagnosis to keep in mind! CVT requires a high index of suspicion and 
meticulous research of predisposing factors (pregnancy, the use of oral contraceptives, maxil-
lofacial infections, malignancies, thrombophilia), because it is a treatable entity with good 
prognosis if early diagnosis and appropriate treatment are undertaken.
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picture in elderly patients or when venous 
impairment is extensive and severe [1-4]. 
Diagnostic confirmation requires the help 
of neuroimaging [14]. Unenhanced CT can 
help especially in the differential diagnosis 
to detect other pathologies. While it may 
show bleeding or venous infarcts, the sensi-
tivity of this method is poor [1-4]. Signs 
classically described as the “cord” (venous or 
sinus hyperdense) or “empty delta” (filling 
defects) are present in only 1/3 of the cases 
after injecting contrast material [1-4]. Ve-
nography by computed tomography is an 
alternative method that can detect quickly 
and accurately the CVT with good sensiti-
vity [1-4]. Current AHA/ASA guidelines 
recommend MRI in T2 sequence and MR 
venography as the test of choice for the dia-
gnosis and follow-up of the CVT [2]. Di-
gital subtraction angiography with venous-
time enhancement should be reserved only 
for cases of doubt or when a therapeutic 
endovascular procedure is necessary [1-4]. 
To complete the diagnosis, it is essential to 
search other predisposing conditions that 
favor the development of thrombotic states 
such as maxillofacial infections, thrombo-
philia or cancer [1-4]. 
The management of the acute phase is 
based on 4 pillars [1-5]:
 y avoiding secondary insults that can aggra-
vate the primary damage; 
Women’s specific  y Pregnancy
 y Puerperium
 y Oral contraceptives
 y Hormonal therapy
thrombofilic states  y Antiphospholipid syndrome
 y Deficiencies of antithrombin, protein C and  S
 y Factor Leiden (V) mutation
 y Prothrombin gene mutation
 y Hyperhomocysteinemia
 y Nephrotic syndrome
Infections  y Otitis, mastoiditis, sinusitis
 y Meningitis
 y Systemic infections
Chronic Inflammatory 
diseases
 y Systemic erithematosous lupus
 y Vasculitides
 y Inflammatory bowel disease
Cancer  y All types
Hematologic disorders  y Polycitemia
 y Essential thrombocytosis
 y Paroxysmal nocturnal hemoglobinuria
trauma  y Traumatic brain injury
 y Maxillo-facial trauma
 y Jugular venous catheterization
 y Neurosurgery
 y Lumbar puncture
table I. Predisposing 
factors for CVT 
development
 y control of seizures, and intracranial hyper-
tension; 
 y anticoagulation; 
 y monitoring of complications that may 
require rescue therapies. 
The best way to avoid secondary insults is 
through physiological homeostasis or neu-
roprotection [6]; that is, simply, to maintain 
basic physiological variables within nor-
mal ranges, ensuring ventilation, adequate 
oxygenation, and hemodynamic stability 
[6] Additionally, a strict control of tempe-
rature, blood glucose and serum sodium is 
very important [6]. Seizure control is no 
different from other circumstances, only we 
emphasize the value of EEG monitoring 
without which it is impossible to detect non-
convulsive states, principally in individuals 
under mechanical ventilation, sedation and 
analgesia [1-5].
Anticoagulation is the key to the therapy 
because it prevents the thrombus propa-
gation, helps the venous recanalization of 
occluded territories, and prevents poten-
tially lethal complications, such as deep vein 
thrombosis and pulmonary embolism [1-5]. 
Despite the controversy regarding anticoa-
gulation in individuals with bleeding or ve-
nous infarctions and based on randomized 
controlled trials, current guidelines recom-
mend starting immediate anticoagulation to 
achieve an INR value between 2 and 3 [2]. 
Unfractionated heparin or low molecular 
weight heparin are safe and effective options, 
and there is no evidence to support the use 
of one rather than the other [1-5].
Generally, the above measures are suffi-
cient to control intracranial hypertension; 
occasionally osmotherapy (hypertonic sali-
ne solutions or mannitol) or external ven-
tricular drainage may be needed [5]. While 
most individuals respond to the therapeutic 
measures mentioned above, some require 
additional procedures such as direct venous 
fibrinolysis through catheter by endovascular 
therapy and/or decompressive craniectomy 
for control of refractory intracranial hyper-
tension [1-5].
Despite the favorable prognosis usually as-
sociated with this disease, the case presented 
here summarizes all aspects of the manage-
ment of a potentially lethal clinical form, 
that can occur in approximately one of every 
four cases of CVT. To avoid diagnostic and 
therapeutic delays, it is essential to consider 
this entity and establish a high index of su-
spicion for individuals with a headache, focal 
neurologic deficits or mental status changes, 
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especially when one or more predisposing 
factors are present. In these cases, a systema-
tic pathway to study and confirm the original 
etiology should trigger. Clinical suspicion of 
CVT requires confirmation with diagnostic 
imaging, preferably MRI. Anticoagulation 
therapy is mandatory, despite the presence 
of cerebral hemorrhages.
Key points
 y CVT is a neurologic emergency that require high suspicion index
 y Screening of predisposing factors is mandatory
 y MRI is a gold standard for diagnosis and follow up
 y Anticoagulation is the key stone of the treatment
 y In certain situations CVT can be life threatening
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proposed ALgorItHM For CerebrAL Venous tHroMbosIs (CVt) 
MAnAgeMent
MRI = magnetic resonance image; MRV = magnetic resonance venography; IV = intravenous;  
LMHW = low molecular heparin weight; INR = international normalized ratio; ICH = intracerebral hemorrhage
